Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Chemotherapy and certain hair care practices can cause severe hair matting.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

The conclusion is that proper communication about the realistic effects of hair loss and skin aging treatments can improve dermatologists' credibility.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Skin issues can indicate immune system problems.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.

Many drugs, not just chemotherapy, can cause reversible hair loss.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.